NO20091375L - Sekvensiell kombinasjonsterapi - Google Patents

Sekvensiell kombinasjonsterapi

Info

Publication number: NO20091375L
Authority: NO; Norway
Prior art keywords: combination therapy; sequential combination; related disorders; angiogenesis; administering
Prior art date: 2006-10-17

Application number

NO20091375A

Other languages

English (en)

Norwegian (no)

Inventor

Rakesh K Jain

Clive R Wood

Daniel T Dransfield

Antonio Arulanandam

Original Assignee

Dyax Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-10-17

Filing date

2009-03-31

Publication date

2009-07-10

2009-03-31 Application filed by Dyax Corp filed Critical Dyax Corp

2009-07-10 Publication of NO20091375L publication Critical patent/NO20091375L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Epidemiology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Microbiology (AREA)
Endocrinology (AREA)
Mycology (AREA)
Dermatology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Urology & Nephrology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Reproductive Health (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

NO20091375A 2006-10-17 2009-03-31 Sekvensiell kombinasjonsterapi NO20091375L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US85226306P	2006-10-17	2006-10-17
US87573606P	2006-12-19	2006-12-19
PCT/US2007/081621 WO2008048996A2 (fr)	2006-10-17	2007-10-17	Thérapie de combinaison séquentielle

Publications (1)

Publication Number	Publication Date
NO20091375L true NO20091375L (no)	2009-07-10

Family

ID=39314809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20091375A NO20091375L (no)	2006-10-17	2009-03-31	Sekvensiell kombinasjonsterapi

Country Status (17)

Country	Link
US (1)	US20080160019A1 (fr)
EP (1)	EP2073826A4 (fr)
JP (1)	JP2010506951A (fr)
KR (1)	KR20090067214A (fr)
AU (1)	AU2007311092A1 (fr)
BR (1)	BRPI0717760A2 (fr)
CA (1)	CA2666714A1 (fr)
CR (1)	CR10798A (fr)
EA (1)	EA200900562A1 (fr)
EC (1)	ECSP099336A (fr)
IL (1)	IL198026A0 (fr)
MA (1)	MA30901B1 (fr)
MX (1)	MX2009004070A (fr)
NI (1)	NI200900057A (fr)
NO (1)	NO20091375L (fr)
TN (1)	TN2009000136A1 (fr)
WO (1)	WO2008048996A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2535171A1 (fr) *	2003-08-12	2005-03-03	Dyax Corp.	Ligands se fixant au tie 1
US20080260861A1 (en) *	2004-04-07	2008-10-23	The General Hospital Corporation	Modulating Lymphatic Function
US20080213253A1 (en) *	2007-01-12	2008-09-04	Dyax Corp.	Combination therapy for the treatment of cancer
EP2156834A1 (fr) *	2008-08-08	2010-02-24	S.I.F.I - Società Industria Farmaceutica Italiana - S.P.A.	Compositions pharmaceutiques ophtalmiques comprenant du Sorafenib pour le traitement de pathologies néoangiogéniques de l'ýil
EP2552482A2 (fr) *	2010-03-31	2013-02-06	Université de Genève	Préparations d'anticorps stabilisés et utilisations correspondantes
US20150003204A1 (en) *	2013-06-27	2015-01-01	Elwha Llc	Tactile feedback in a two or three dimensional airspace
US9804675B2 (en)	2013-06-27	2017-10-31	Elwha Llc	Tactile feedback generated by non-linear interaction of surface acoustic waves

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6887468B1 (en) *	1999-04-28	2005-05-03	Board Of Regents, The University Of Texas System	Antibody kits for selectively inhibiting VEGF
US20040132675A1 (en) *	2002-02-08	2004-07-08	Calvin Kuo	Method for treating cancer and increasing hematocrit levels
US7485297B2 (en) *	2003-08-12	2009-02-03	Dyax Corp.	Method of inhibition of vascular development using an antibody
CA2535171A1 (fr) *	2003-08-12	2005-03-03	Dyax Corp.	Ligands se fixant au tie 1
US7871610B2 (en) *	2003-08-12	2011-01-18	Dyax Corp.	Antibodies to Tie1 ectodomain
AU2005272848A1 (en) *	2004-08-12	2006-02-23	Dyax Corp.	Tie complex binding proteins
US20080213253A1 (en) *	2007-01-12	2008-09-04	Dyax Corp.	Combination therapy for the treatment of cancer

2007
- 2007-10-17 EP EP07854125A patent/EP2073826A4/fr not_active Withdrawn
- 2007-10-17 US US11/873,856 patent/US20080160019A1/en not_active Abandoned
- 2007-10-17 WO PCT/US2007/081621 patent/WO2008048996A2/fr not_active Ceased
- 2007-10-17 KR KR1020097009954A patent/KR20090067214A/ko not_active Withdrawn
- 2007-10-17 CA CA002666714A patent/CA2666714A1/fr not_active Abandoned
- 2007-10-17 MX MX2009004070A patent/MX2009004070A/es unknown
- 2007-10-17 JP JP2009533500A patent/JP2010506951A/ja not_active Withdrawn
- 2007-10-17 BR BRPI0717760-7A2A patent/BRPI0717760A2/pt not_active IP Right Cessation
- 2007-10-17 EA EA200900562A patent/EA200900562A1/ru unknown
- 2007-10-17 AU AU2007311092A patent/AU2007311092A1/en not_active Abandoned
2009
- 2009-03-31 NO NO20091375A patent/NO20091375L/no not_active Application Discontinuation
- 2009-04-06 IL IL198026A patent/IL198026A0/en unknown
- 2009-04-13 TN TNP2009000136A patent/TN2009000136A1/fr unknown
- 2009-04-16 NI NI200900057A patent/NI200900057A/es unknown
- 2009-05-14 MA MA31888A patent/MA30901B1/fr unknown
- 2009-05-15 CR CR10798A patent/CR10798A/es not_active Application Discontinuation
- 2009-05-15 EC EC2009009336A patent/ECSP099336A/es unknown

Also Published As

Publication number	Publication date
MA30901B1 (fr)	2009-11-02
JP2010506951A (ja)	2010-03-04
WO2008048996A3 (fr)	2008-07-03
NI200900057A (es)	2010-02-02
WO2008048996A2 (fr)	2008-04-24
WO2008048996A9 (fr)	2008-09-12
KR20090067214A (ko)	2009-06-24
US20080160019A1 (en)	2008-07-03
ECSP099336A (es)	2009-06-30
EP2073826A2 (fr)	2009-07-01
CA2666714A1 (fr)	2008-04-24
AU2007311092A1 (en)	2008-04-24
CR10798A (es)	2009-06-09
EP2073826A4 (fr)	2010-12-15
IL198026A0 (en)	2011-08-01
TN2009000136A1 (en)	2010-10-18
EA200900562A1 (ru)	2009-10-30
MX2009004070A (es)	2009-04-27
BRPI0717760A2 (pt)	2013-11-12

Publication	Publication Date	Title
NO20091375L (no)	2009-07-10	Sekvensiell kombinasjonsterapi
CY1121135T1 (el)	2019-12-11	Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
EA200970317A1 (ru)	2009-10-30	Комбинированное лечение опухолей, экспрессирующих cd38
EA200971077A1 (ru)	2010-04-30	Гетероциклические модуляторы киназы
MX2010002732A (es)	2010-06-02	Inhibidores de f1f0-atpasa y metodos relacionados.
CR9874A (es)	2008-08-01	Dipeptidyl peptidase inhibitors for treating diabetes
EA200900091A1 (ru)	2009-06-30	Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний
EP1929123A4 (fr)	2011-03-09	Procede et appareil de traitement de puits par stimulation
BRPI0817775A2 (pt)	2015-03-24	Métodos de tratar distúrbios urogenitais-neurológicos usando toxinas clostridiais modificadas
NO20083002L (no)	2008-08-14	Fremgangsmate for anvendelse av CD40-bindende forbindelser
EP2303918A4 (fr)	2012-08-15	Procédés pour administrer un antagoniste d activine-actriia et surveiller des patients traités
EP2212350A4 (fr)	2011-01-05	Méthodes thérapeutiques et diagnostiques utilisant le tim-3
MX2012000817A (es)	2012-05-08	Tratamiento para desordenes del higado con inhibidores pi3k.
BRPI0908276B8 (pt)	2021-05-25	uso de um anticorpo antagonista anti-cgrp para a fabricação de um medicamento para a prevenção e/ou tratamento de dor de osteoartrite
MX375194B (es)	2025-03-06	Tratamiento de cánceres utilizando moduladores de las isoformas de pi3 cinasa.
EA200870185A1 (ru)	2008-12-30	Комбинации ингибиторов ang2 и vegf
NO20084374L (no)	2008-11-05	Imidazoltiazolforbindelser for behandling av sykdom
EP1909904A4 (fr)	2012-06-20	Methodes et appareil pour planifier et pour administrer des traitements de radiotherapie
EP2063881A4 (fr)	2012-11-07	Composition et méthode pour administrer efficacement et sans danger un halopyruvate pour traiter un cancer
EA201070609A1 (ru)	2010-12-30	Способы лечения ожирения и ассоциированных с ожирением заболеваний и расстройств
MX2010004494A (es)	2010-08-30	Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios.
LT2318188T (lt)	2019-03-12	Medienos plokštės apdorojimo būdas
BRPI0906094B8 (pt)	2021-05-25	composto
EA201101568A1 (ru)	2012-05-30	Лечение ex vivo иммунологических нарушений с помощью ингибиторов pkc-teta
EA201201464A1 (ru)	2013-04-30	Новая комбинированная терапия для лечения онкологических и фиброзных заболеваний

Legal Events

Date	Code	Title	Description
2012-06-04	FC2A	Withdrawal, rejection or dismissal of laid open patent application